The complicated and confusing debate about statins – are they worth taking or not; are they safe or do they have nasty side effect? – has suddenly plunged into anarchic and uncharted territory by the claims of a new rival drug.
Post Tagged with: "Cholesterol"
We are being doctored to death. GPs’ surgeries and public health bodies routinely warn of hazards lurking all around us. They tell us sunshine is bad. Drinking alcohol is bad. Cholesterol is bad. Saturated fat is bad. Being overweight is bad.
If you aren’t confused about what is going on with statins then you haven’t been paying attention. As an example of just how convoluted it’s getting, take the email forwarded to me last week that had gone to members of the British Cardiovascular Society (BCS) asking them to fill in a short survey about any patients who had stopped taking statins… (Read More…)
Arriving at the debate on statins run by the Guild of Health Writers last week , I was very amused to discover that the redoubtable Professor Sir Rory Collins, arch champion of statins for-all and hammer of the BMJ, had declined to appear when told that indefatigable statin critic Dr Malcolm Kendrick, was speaking . Perhaps he’s realised his style of steamrollering critics is a PR disaster. … (Read More…)
Increasingly people are questioning whether it’s worth taking statins, the cholesterol-lowering drugs that are supposed to cut your risk of developing heart disease. We think they are a really bad idea, unless you’ve already got heart disease, and have explained why… (Read more…)
About ten years ago for various personal reasons I became interested in the benefits of an Atkins-type low carbohydrate diet. I read a lot of research material, talked to many experts and became convinced that the advice to follow a low fat/high carbohydrate diet has been disastrous for our national health. (Read more…)
The ‘Cochrane Collaboration’ is an international collective of researchers whose self-proclaimed role is to provide accurate and robust appraisals of health interventions. The group specialises in ‘meta-analyses’: the grouping together of several similar studies on interventions including drug therapies…